NCT02158143

Brief Summary

evaluated the effect and safety of a single high dose of cholecalciferol in Chinese young people.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2014

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 5, 2014

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 6, 2014

Completed
Last Updated

June 6, 2014

Status Verified

June 1, 2014

Enrollment Period

6 months

First QC Date

June 5, 2014

Last Update Submit

June 5, 2014

Conditions

Outcome Measures

Primary Outcomes (5)

  • Effect of vitamin D3 supplementation on serum 25(OH)D changes

    within 140 day after supplementation

  • Effect of vitamin D3 supplementation on serum PTH

    within 140 day after supplementation

  • Effect of vitamin D3 supplementation on serum calcium

    within 140 day after supplementation

  • Effect of vitamin D3 supplementation on serum creatinine

    within 140 day of supplementation

  • Effect of vitamin D3 supplementation on urinary calcium / creatinine

    within 140 day after supplementation

Secondary Outcomes (2)

  • Effect of vitamin D3 supplementation on fasting blood glucose

    within 140 day after supplementation

  • Effect of vitamin D3 supplementation on serum lipids

    within 140 day after supplementation

Study Arms (1)

vitamin D3

EXPERIMENTAL
Dietary Supplement: vitamin D3

Interventions

vitamin D3DIETARY_SUPPLEMENT
vitamin D3

Eligibility Criteria

Age25 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy, younger, Chinese Hans aged from 25-35 years, including 25 and 35 years;
  • haven't taken vitamin D supplement for the past 6 months;
  • with a normal BMI (18-25 kg/m2);
  • with baseline serum 25(OH)D \< 30 ng/ml;
  • be willing to follow the instruction and complete the study.

You may not qualify if:

  • clinically diagnosed cardiovascular disease, gastrointestinal disease, endocrine, blood, liver, lung, kidney, nerve or mental illness;
  • self-reported current use of any dietary supplements containing vitamin D within the 6 months before enrollment;
  • Severe anemia (hemoglobin concentration \< 70 g/L);
  • Serum 25(OH)D ≥ 30 ng/mL at enrollment;
  • participating in other research studies within the 3 months before enrollment;
  • history of drug dependence or drug abuse;
  • History of heavy drinking (drinking 14 cups or more per week, equivalent to 360 mL beer or 150 mL white wine or 45 mL liquor per cup) and smokers (more than 10 cigarette per day);
  • clinical abnormal of blood biochemistry, hematology or urine laboratory values;
  • current pregnancy or lactation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institute for Nutrition Sciences, Chinese Academy of Sciences

Shanghai, Shanghai Municipality, 200031, China

Location

MeSH Terms

Conditions

Vitamin D Deficiency

Interventions

Cholecalciferol

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

CholestenesCholestanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSterolsVitamin DSecosteroidsMembrane LipidsLipids

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 5, 2014

First Posted

June 6, 2014

Study Start

October 1, 2013

Primary Completion

April 1, 2014

Last Updated

June 6, 2014

Record last verified: 2014-06

Locations